OTHER · Unmapped registry intervention
ofatumumab
Find medicine records ·
Find other trials using this name
Clinical trial
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
NCT05344469
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
glatiramer acetate
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
interferon β1
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
teriflunomide
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
dimethyl fumarate (DMF)
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
diroximel fumarate (DRF)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Relapsing Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05344469 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.